Abstract
Introduction
Head and neck squamous cell carcinoma (HNSCC) is one of the most invasive cancer types globally, and distant metastasis (DM) is associated with a poor prognosis. The objective of this study was designed to construct a novel nomogram and risk classification system to predict overall survival (OS) in HNSCC patients presenting with DM at initial diagnosis.
Methods
HNSCC patients with initially diagnosed DM between 2010 and 2015 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Firstly, all patients were randomly assigned to a training cohort and validation cohort (8:2), respectively. The Cox proportional hazards regression model was used to analyze the prognostic factors associated with OS. Then, the nomogram based on the prognostic factors and the predictive ability of the nomogram were assessed by the calibration curves, receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Finally, a risk classification system was established according to the nomogram scores.
Results
A total of 1240 patients initially diagnosed with HNSCC with DM were included, and the 6-, 12- and 18-month OS of HNSCC with DM were 62.7%, 40.8% and 30%, respectively. The independent prognostic factors for HNSCC patients with DM included age, marital status, primary site, T stage, N stage, bone metastasis, brain metastasis, liver metastasis, lung metastasis, surgery, radiotherapy and chemotherapy. Based on the independent prognostic factors, a nomogram was constructed to predict OS in HNSCC patients with DM. The C-index values of the nomogram were 0.713 in the training cohort and 0.674 in the validation cohort, respectively. The calibration curves and DCA also indicated the good predictability of the nomogram. Finally, a risk classification system was built and it revealed a statistically significant difference among the three groups of patients according to the nomogram scores.
Conclusions
Factors associated with the overall survival of HNSCC patients with DM were found. According to the identified factors, we generated a nomogram and risk classification system to predict the OS of patients with initially diagnosed HNSCC with DM. The prognostic nomogram and risk classification system can help to assess survival time and provide guidance when making treatment decisions for HNSCC patients with DM.
Similar content being viewed by others
Availability of data and materials
The dataset from SEER database generated and/or analyzed during the current study are available in the SEER dataset repository (https://seer.cancer.gov/).
Abbreviations
- HNSCC:
-
Head and neck squamous cell carcinoma
- DM:
-
Distant metastasis
- OS:
-
Overall survival
- SEER:
-
Surveillance epidemiology and end results
- AJCC:
-
American Joint Committee on Cancer
- ROC:
-
Receiver operating characteristic
- AUC:
-
Area under the curve
- DCA:
-
Decision curve analysis
- HR:
-
Ratio
- CI:
-
Confidence interval
References
Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Tahara M, Muro K, Hasegawa Y et al (2018) Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: analyses from KEYNOTE-012. Cancer Sci 109:771–776. https://doi.org/10.1111/cas.13480
Guigay J, Auperin A, Fayette J et al (2021) Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014–01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 22:463–475. https://doi.org/10.1016/S1470-2045(20)30755-5
Guigay J, Fayette J, Dillies AF et al (2015) Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. Ann Oncol 26:1941–1947. https://doi.org/10.1093/annonc/mdv268
Duprez F, Berwouts D, De Neve W et al (2017) Distant metastases in head and neck cancer. Head Neck 39:1733–1743. https://doi.org/10.1002/hed.24687
Adkins DR, Lin JC, Sacco A et al (2021) Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naive, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial. Oral Oncol 115:105192. https://doi.org/10.1016/j.oraloncology.2021.105192
Liu JC, Bhayani M, Kuchta K et al (2019) Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation. Oral Oncol 88:131–136. https://doi.org/10.1016/j.oraloncology.2018.11.023
Kuperman DI, Auethavekiat V, Adkins DR et al (2011) Squamous cell cancer of the head and neck with distant metastasis at presentation. Head Neck 33:714–718. https://doi.org/10.1002/hed.21529
Lim JY, Lim YC, Kim SH et al (2010) Predictive factors of isolated distant metastasis after primary definitive surgery without systemic treatment for head and neck squamous cell carcinoma. Oral Oncol 46:504–508. https://doi.org/10.1016/j.oraloncology.2010.02.005
Coca-Pelaz A, Rodrigo JP, Suarez C (2012) Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas. Head Neck 34:771–775. https://doi.org/10.1002/hed.21804
Li X, Di B, Shang Y et al (2009) Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. Eur J Surg Oncol 35:1348–1353. https://doi.org/10.1016/j.ejso.2009.06.010
Nishijima W, Takooda S, Tokita N et al (1993) Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg 119:65–68. https://doi.org/10.1001/archotol.1993.01880130067009
Zbaren P, Lehmann W (1987) Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy. Arch Otolaryngol Head Neck Surg 113:762–764. https://doi.org/10.1001/archotol.1987.01860070076020
Tang X, Pang T, Yan WF et al (2020) A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. BMC Cancer 20:1095. https://doi.org/10.1186/s12885-020-07599-2
Hoch S, Katabi N, Daniel H et al (2016) Prognostic value of level IV metastases from head and neck squamous cell carcinoma. Head Neck 38:140–146. https://doi.org/10.1002/hed.23861
Balachandran VP, Gonen M, Smith JJ et al (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173-180. https://doi.org/10.1016/S1470-2045(14)71116-7
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590
Xiao C, Miller AH, Peng G et al (2021) Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 111:157–167. https://doi.org/10.1016/j.ijrobp.2021.04.002
Simpson MC, Challapalli SD, Cass LM et al (2019) Impact of gender on the association between marital status and head and neck cancer outcomes. Oral Oncol 89:48–55. https://doi.org/10.1016/j.oraloncology.2018.12.009
Inverso G, Mahal BA, Aizer AA et al (2015) Marital status and head and neck cancer outcomes. Cancer 121:1273–1278. https://doi.org/10.1002/cncr.29171
Schaefer EW, Wilson MZ, Goldenberg D et al (2015) Effect of marriage on outcomes for elderly patients with head and neck cancer. Head Neck 37:735–742. https://doi.org/10.1002/hed.23657
Takes RP, Rinaldo A, Silver CE et al (2012) Distant metastases from head and neck squamous cell carcinoma. Part I Basic aspects. Oral Oncol 48:775–779. https://doi.org/10.1016/j.oraloncology.2012.03.013
Du E, Mazul AL, Farquhar D et al (2019) Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status. Laryngoscope 129:2506–2513. https://doi.org/10.1002/lary.27807
Shen W, Sakamoto N, Yang L (2015) Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Ann Surg Oncol 22:264–271. https://doi.org/10.1245/s10434-014-3951-8
van der Kamp MF, Muntinghe FOW, Iepsma RS et al (2021) Predictors for distant metastasis in head and neck cancer, with emphasis on age. Eur Arch Otorhinolaryngol 278:181–190. https://doi.org/10.1007/s00405-020-06118-0
Bollig CA, Newberry CI, Galloway TLI et al (2021) Prognostic impact of metastatic site and pattern in patients with metastatic head and neck cancer. Laryngoscope 131:E1838–E1846. https://doi.org/10.1002/lary.29208
Patel TD, Marchiano E, Chin OY et al (2016) Utility of surgery/radiotherapy in distant metastatic head and neck squamous cell carcinoma: a population-based approach. Otolaryngol Head Neck Surg 154:868–874. https://doi.org/10.1177/0194599815627637
Chow LQM (2020) Head and neck cancer. N Engl J Med 382:60–72. https://doi.org/10.1056/NEJMra1715715
Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127. https://doi.org/10.1056/NEJMoa0802656
Kabarriti R, Baliga S, Ohri N et al (2019) Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma. Head Neck 41:130–138. https://doi.org/10.1002/hed.25476
Li W, Xiao Y, Xu X et al (2021) A novel nomogram and risk classification system predicting the cancer-specific mortality of patients with initially diagnosed metastatic cutaneous melanoma. Ann Surg Oncol 28:3490–3500. https://doi.org/10.1245/s10434-020-09341-5
Tang X, Zhou X, Li Y et al (2019) A novel nomogram and risk classification system predicting the cancer-specific survival of patients with initially diagnosed metastatic esophageal cancer: a SEER-based study. Ann Surg Oncol 26:321–328. https://doi.org/10.1245/s10434-018-6929-0
Lan LF, Gao CK, Ma CW (2021) Prediction of minor salivary gland carcinoma: a novel nomogram and risk classification system for overall survival and cancer-specific survival. Otolaryngol Head Neck Surg 164:359–368. https://doi.org/10.1177/0194599820938323
Chi C, Fan Z, Yang B et al (2021) The clinical characteristics and prognostic nomogram for head and neck cancer patients with bone metastasis. J Oncol 2021:5859757. https://doi.org/10.1155/2021/5859757
Acknowledgements
Not applicable.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
Study design: R-QZ, Y-MZ, and H-YZ. Data collection: W-YS and X-YL. Manuscript preparation: R-QZ, Y-MZ. Data analysis and interpretation: R-QZ and W-YS. H-YZ participated in the design of the study and drafted the manuscript. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval and informed consent
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhu, RQ., Zhang, YM., Luo, XY. et al. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis. Eur Arch Otorhinolaryngol 280, 1467–1478 (2023). https://doi.org/10.1007/s00405-022-07716-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-022-07716-w